COMPARISON OF THE EFFECTIVENESS OF EXTRACORPOREAL SHOCKWAVE THERAPY (ESWT) AND TADALAFIL ON ORGANIC ERECTILE DYSFUNCTION

##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

PDF
Published 2020-01-22
Indra Wiradinata Yefri Zulfiqar Etriyel Myh Hardisman

Abstract

Objective: To find a comparison of the effectiveness of ESWT and Tadalafil on organic erectile dysfunction. Material & Methods: This is a Quasi Experiment study that was carried out from February 2018 to April 2018. ESWT treatment was performed in Urology Outpatient Clinic. Cialis 10 mg was used in cased of Tadalafil. The sample size is 40 patients consists of 20 patients each treatment. The data was processed with a significance limit of p<0.05. Results: The sample age average is 61.7 years, the level of total cholesterol is 191 mg/dL, FBG 112.5 mg/dL, 2hPPBG 134.5 mg/dL, HDL 44.9 mg/dL, LDL 137.5 mg/dL, ureum 27 mg/dL, and creatinin 0.8 mg/dL. The proportion of Diabetes Mellitus patients in this study is 50% and hypertension 57.5%, which is 15% of them belong to mild erectile dysfunction category, 37.5% mild to moderate,  5%  moderate, and 42.5%  severe. We found an increasement of EHS on 75% patients that were treated with ESWT and 5% on patient that were treated with Tadalafil, and it is statistically significant (p<0.05). Conclusion: We found that ESWT and Tadalafil can increase EHS of organic erectile dysfunction patients, which ESWT is more effective than Tadalafil.


##plugins.themes.bootstrap3.article.details##

Keywords

Erectile Dysfunction, ESWT, Tadalafil, Erection Hardness Score

References

Sumampouw AM, Tendean L, Wantouw B. Penanganan disfungsi ereksi secara dini. Dalam Jurnal Kedokteran Komunitas dan Tropik. 2015; 3(3): 196-1999.

Smith-Harrison, Patel A, Smith RP. The devil is in the details: an analysis of the subtleties between phosphodiesterase inhibitors for erectile dysfunction. In Transl Androl Urol. 2015; 5(2): 181-186.

Kirby R. An Atlas of Erectile Dysfunction 2nd edition. The Parthenon Publishing Group. London; 2004.

Sugiharso MA, Saraswati MR. Hubungan disfungsi ereksi pada penderita Diabetes Melitus tipe 2 terhadap kualitas hidup di Poliklinik Penyakit Dalam RSUP Sanglah Provinsi Bali. Dalam E-Jurnal Medika. 2016; 5(5): 1-8.

Saraswati MR, Sanjaya D, Suastika K.Prediktor disfungsi ereksi pada penderita Diabetes tipe 2 di Poliklinik Penyakit Dalam RS Sanglah Denpasar. Dalam J Peny Dalam. 2008; 9(2): 129-133.

Lue T. Physiology of penile erection and pathophysiology of erectile dysfunction. In Campbell-Walsh Urology 10th edition. Philadelphia: Saunders Elsevier; 2012. p. 688-720.

Chen L, Staubli S, Schneider M, Kessels A, Ivic S, Bachmann L, Kessler T. Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: A trade-off network meta-analysis. In European Association of Urology. 2015; 68: 674-680.

Lei H, Liu J, Li H, Wang L, Xu Y, Tian W, Lin G, et al. Low-intensity shock wave therapy and its application to erectile dysfunction. In World J Mens Health. 2013; 31(3): 208-214.

Qiu X, Lin G, Xin Z, Ferretti L, Zhang H, Lue TF, Lin CS. Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model. In J Sex Med. 2013; 10: 738-746.

Olsen A, Persiani M, Boie S, Hanna M, Lund L. Can low-intensity extracorporeal shockwave therapy improve erectile dysfunction? A prospective, randomized, double-blind, placebo-controlled study. In Scandinavian Journal of Urology. 2014: 1-5.

Kimura M, Shimura S, Tai T, Kobayashi H, Baba S, Kano M, Nagao K. A web-based survey of erection hardness score and its relationship to aging, sexual behaviour, confidence, and risk factors in Japan. In Sex Med. 2013; 1: 76-86.

Skeldon S, Detsky A, Godenberg S, Law M. erectile dysfunction and undiagnosed diabetes, hypertension, and hypercholesterolemia. In Annals of Family Medicine. 2015; 13(4): 331-334.

Papadopoulou E, Varouktsi A, Lazaridis A, Boutari C, Doumas M. Erectile dysfunction in chronic kidney disease: From pathophysiology to management. In WJN. 2014; 4: 379-387.

Wylie K, Maclness I. Erectile Dysfunction. In handbook of sexual dysfunction. Taylor and Francis Group, NewYork. 2005: 156-185.

Reisman Y, Hind A, Varaneckas A, Motil I. Efficacy and safety of linear focused shockwaves for erectile dysfunction (RENOVA)-a second generation technology. In Clinical Review of Low Intensity Shockwave Theraphy. 2013.

Vardi Y, Appel B, Kilchevsky A, Gruenwald I. Does low intensity shock wave therapy have a physiological effect on erectile function? Short term results of a randomized, double-blind, sham controlled study. In The Journal of Urology. 2012; 187: 1769-1775.

Gruenwald I, Kitrey N, Appel B, Vardi Y. Low-intensity extracorporeal shock waves therapy in vascular disease and erectile dysfunction: Theory and Outcomes. In Sex Med Rev. 2013; 1: 83-90.

Park K, Hwang E, Kim S. Prevalence and medical management of erectile dysfunction in Asia. In Asian Journal of Andrology. 2011; 13: 543-549.

Section
Articles
Copyright Information
Department of Urology, Faculty of Medicine/Airlangga University